References
- Roberts BR, Tainer JA, Getzoff ED, Malencik DA, Anderson SR, Bomben VC, et al. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J Mol Biol. 2007; 373: 877–90
- Yamashita H, Kawamata J, Okawa K, Kanki R, Nakamizo T, Hatayama T, et al. Heat shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS. J Neurochem. 2007; 102: 1497–505
- Smith AP, Lee NM. Role of zinc in ALS. Amyotroph Lateral Scler. 2007; 8: 131–43
- Frederickson CJ, Klitenick MA, Manton WI, Kirkpatrick JB. Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Res. 1983; 273: 335–9
- Choi DW, Yokoyama M, Koh J. Zinc neurotoxicity in cortical cell culture. Neuroscience. 1988; 24: 67–79
- Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW. The role of zinc in selective neuronal death after transient global cerebral ischaemia. Science. 1996; 272: 1013–6
- Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, et al. Induction of nitric oxide dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 1999; 286: 2498–500
- Weiss JH, Sensi SL, Koh JY. Zn2+: a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci. 2000; 21: 395–401
- Ross GM, Shamovsky IL, Lawrance G, Solc M, Dostaler SM, Jimmo SL, et al. Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins. Nat Med. 1997; 38: 872–8
- Martinou JC, Martinou I, Kato AC. Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motor neurons in vitro. Neuron. 1992; 8: 737–44
- Bataille S, Portalier P, Coulon P, Ternaux JP. Influence of acetylcholinesterase on embryonic spinal rat motor neurons growth in culture: a quantitative morphometric study. Eur J Neurosci. 1998; 10: 560–72
- Shamovsky IL, Ross GM, Riopelle RJ, Weaver DF. The interaction of neurotrophins with the p75NTR common neurotrophin receptor: a comprehensive molecular modelling study. Protein Sci. 1999; 8: 2223–33
- Escandon E, Burton LE, Szonyi E, Nikolics K. Characterization of neurotrophin receptors by affinity cross-linking. J Neurosci Res. 1993; 34: 601–13
- Soppet D, Escandon E, Maragos J, Middlemas DS, Reid SW, Blair J, et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell. 1991; 65: 895–903
- Figlewicz DA, Dong L, Mlodzienski M, Turcotte JC. Culture models of neurodegenerative disease. Ann N Y Acad Sci. 2000; 919: 106–18
- Kim YH, Kim EY, Gwag BJ, Sohn S, Koh JY. Zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals. Neuroscience. 1999; 89: 175–82
- Azzouz M, Poindron P, Guettier S, Leclerc N, Andres C, Warter JM, et al. Prevention of mutant SOD1 motor neuron degeneration by copper chelators in vitro. J Neurobiol. 2000; 42: 49–55
- Brown RH, Jr. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr Opin Neurobiol. 1995; 5: 841–6
- Wang W, Post JI, Dow KE, Shin SH, Riopelle RJ, Ross GM. Zinc and copper inhibit nerve growth factor-mediated protection from oxidative stress-induced apoptosis. Neurosci Lett. 1999; 259: 115–8
- Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an anti-apoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA. 1995; 92: 3024–8
- Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 1996; 271: 515–8